Clinical trial
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension…
NCT00208221 · Institut de Recherches Cliniques de Montreal, Other · Terminated
Key facts
| NCT number | NCT00208221 |
|---|---|
| Title | Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes |
| Official title | Comparison of a Higher Dose of Ramipril to the Addition of Telmisartan 80 mg+Ramipril 10 mg in Patients With Hypertension and Diabetes |
| Lead sponsor | Institut de Recherches Cliniques de Montreal, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Type 2 Diabetes, Albuminuria |
| Intervention type | Drug |
| Interventions | ramipril, ramipril-telmisartan |
| Enrollment | 50 |
| Start date | Aug 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 8, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: